Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.
Rubin RH, et al. Among authors: blumberg ea.
Transpl Infect Dis. 2000 Sep;2(3):112-7.
Transpl Infect Dis. 2000.
PMID: 11429021
Clinical Trial.